By acting on appetite centers in the brain, especially the hypothalamus, semaglutide reduces hunger, cravings, and desire to eat
Are Overweight or Obese: Those with a BMI of 27 or higher, especially if they have weight-related health issues, may find Semaglutide effective for weight management
3.7 out of 5 from GLP-1.Reviews, reflecting its exceptional BBB record and consistent patient satisfaction alongside a still-developing clinical support infrastructure
Based on what we see at our Doral clinic, the patients who benefit most look like this: A soft-tissue injury that stalled: physical therapy is complete, there is no surgical indication, but the patient is still symptomatic at 8 to 12 weeks
For maintenance, a low dose (100 mcg once daily) may suffice
However, if a patient with PAD also has diabetes or obesity, then yes, I might prescribe a GLP-1